Lataa...
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
Chronic myeloid leukemia (CML) is the paradigm for targeted cancer therapy. RT-qPCR is the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy based on the reduction of blood or bone marrow BCR-ABL1. Some patients with CML and very low or undetectable levels of BCR-ABL1...
Tallennettuna:
| Julkaisussa: | Biomol Detect Quantif |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348117/ https://ncbi.nlm.nih.gov/pubmed/28331814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bdq.2017.01.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|